InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Gault Cheryl. Director active across 1 company, notably Rapport Therapeutics, Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €296k. History available since 3 March 2025. The latest transaction was disclosed on 30 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Gault Cheryl is a declarant with 4 filings in total. Among the 4 sampled recent filings between 2025-03-05 and 2026-03-31, all at Rapport Therapeutics, Inc. (XNAS), the sell amount totals EUR 245949 and the modal transaction nature is Sale. As no primary role is provided, no title is stated.